Biomanufacturing of Tomorrow Requires a Connected Company Today
Next-generation cell-based therapy and gene editing therapeutics are set to revolutionize medicine. However, to harness the scientific potential of these drugs, biomanufacturing organizations must develop new systems to handle the increased complexity of process development, manufacturing operations, and quality assurance associated with these new therapeutics. In this blog post, we discuss the shortcomings of legacy …
Read more “Biomanufacturing of Tomorrow Requires a Connected Company Today”